Jason Loveridge is the CEO of 4SC AG, a clinical-stage biopharmaceutical company based in Planegg-Martinsried, Germany. Based in Planegg-Martinsried, Germany.
Jason Loveridge is the CEO of 4SC AG, a clinical-stage biopharmaceutical company based in Planegg-Martinsried, Germany. 4SC focuses on developing small-molecule drugs for cancer, with two drug candidates, resminostat and domatinostat, currently in clinical development. The company raised approximately EUR 7.5 million in a capital increase in November 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library